Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Autoimmune myocarditis is an autoimmune disease that affects the heart. The condition is characterized by inflammation of the heart muscle (myocardium). Some people with autoimmune myocarditis have no noticeable symptoms of the condition. When present, signs and symptoms may include chest pain, abnormal heartbeat, shortness of breath, fatigue, signs of infection (i.e. fever, headache, sore throat, diarrhea), and leg swelling. The exact underlying cause of the condition is currently unknown; however, autoimmune conditions, in general, occur when the immune system mistakenly attacks healthy tissue. Treatment is based on the signs and symptoms present in each person. In some cases, medications that suppress the immune system may be recommended.
Biomarker and diagnostic research for autoimmune myocarditis has been reported in the published literature.
No clinical trials have been registered for autoimmune myocarditis.
82 publications have been identified in PubMed for autoimmune myocarditis. Research spans Basic Science / Preclinical (54%), Review / Meta-Analysis (11%), and Gene Therapy / Novel Therapeutics (11%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 44 | 54% |
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 11:10 AM UTC
Genetic and Rare Diseases Info Center
9 |
11% |
New treatment approaches | 9 | 11% |
Patient case studies | 8 | 10% |
Testing and diagnosis research | 4 | 5% |
Clinical study results | 4 | 5% |
Disease patterns and progression | 3 | 4% |
Other research | 1 | 1% |
Hsiao YW (2026). [PMID: 42177700](https://pubmed.ncbi.nlm.nih.gov/42177700/). *Basic Res Cardiol*. [Basic Science / Preclinical]
Melnikova EA (2026). [PMID: 42026355](https://pubmed.ncbi.nlm.nih.gov/42026355/). *Bull Exp Biol Med*. [Basic Science / Preclinical]
Li Y (2026). [PMID: 41905163](https://pubmed.ncbi.nlm.nih.gov/41905163/). *Biochem Biophys Res Commun*. [Basic Science / Preclinical]
Sur M (2026). [PMID: 41677760](https://pubmed.ncbi.nlm.nih.gov/41677760/). *Biology*. [Basic Science / Preclinical]
Song Y (2026). [PMID: 41650238](https://pubmed.ncbi.nlm.nih.gov/41650238/). *Proceedings of the National Academy of Sciences of the United States of America*. [Basic Science / Preclinical]
Ruiz-Fernández I (2026). [PMID: 42051316](https://pubmed.ncbi.nlm.nih.gov/42051316/). *bioRxiv*. [Basic Science / Preclinical]
Bakhru S (2026). [PMID: 41384905](https://pubmed.ncbi.nlm.nih.gov/41384905/). *JACC. Case reports*. [Case Report / Case Series]
Zhuang Y (2026). [PMID: 41412038](https://pubmed.ncbi.nlm.nih.gov/41412038/). *Redox biology*. [Basic Science / Preclinical]
Hou Y (2026). [PMID: 41144157](https://pubmed.ncbi.nlm.nih.gov/41144157/). *Science China. Life sciences*. [Review / Meta-Analysis]
McNamara DM (2026). [PMID: 41711722](https://pubmed.ncbi.nlm.nih.gov/41711722/). *ESC heart failure*. [Clinical Trial Publication]